血管生长抑制素癌抑素研究进展
摘要
肿瘤生长和动脉粥样硬化的发展与新生血管的形成有一定的关系,该文就一种新的血管生长抑制素癌抑素(canstatin)在血管内皮细胞的增殖、迁移和凋亡中作用以及在肿瘤、心血管疾病防治作用和意义作一综述。
出处
《国际检验医学杂志》
CAS
2006年第6期553-555,共3页
International Journal of Laboratory Medicine
参考文献13
-
1Kamphaus GD, Colorado PC, Panka DJ, et al. canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem, 2000, 275(2): 1209-1215.
-
2Habeck M. Wielding more power over angiogenesis. Mol Med Today. 2000. 6(4): 138-139.
-
3He GA, Luo JX, Zhang TY, et al. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem Biophys Res Commun, 2004, 318(2):354-360.
-
4侯卫红,王天云,柴玉荣,袁保梅,侯桂琴,王建民,薛乐勋.小鼠canstatin及其N端片段在大肠杆菌BL21中的表达[J].遗传,2004,26(5):658-662. 被引量：2
-
5He GA, Luo JX, Zhang TY, et al. Expression and purification of the N-domain of human canstatin and its bioactivity. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 2003, 35(5):483-487.
-
6He GA, Luo JX, Zhang TY, et al. canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. Biochem Biophys Res Commun, 2003, 312(3): 801-805.
-
7Panka DJ, Mier JW. canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem, 2003,278(39): 37632-37636.
-
8Liu G, Guibao CD, Zheng J. Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase. Mol Cell Biol, 2002, 22(8): 2751-2760.
-
9Panka DJ, Mano T, Suhara T, et al. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem, 2001, 276(10): 6893-6896.
-
10Sudhakar A, Sugimoto H, Yang C, et al, Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA, 2003, 100(8): 4766-4771.
二级参考文献4
-
1O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin:a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J].Cell,1994,79(2):315-328.
-
2O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
-
3Kamphaus GD,Colorado PC,Panka DJ,et al.Canstatin,a novel matrix-derived inhibitor of angiogenesis and tumor growth[J].J Biol Chem,2000,275(2):1209-1215.
-
4李浪,冯建章,郑文岭.血管生成抑制素canstatin的新发现[J].中国病理生理杂志,2002,18(7):862-864. 被引量：6
共引文献3
-
1陆卫忠,李玉英,余时沧,李瑾,黄桂君.Canstatin基因转染对体外培养血管内皮细胞增殖与凋亡的影响[J].心脏杂志,2006,18(3):265-268. 被引量：1
-
2王毅,刘志明,邹静,习国平,张运波,赖春红.结缔组织生长因子在鼻息肉中的分布和表达[J].中国耳鼻咽喉头颈外科,2011,18(7):378-380. 被引量：2
-
3史文荣,王雪雯.血管能抑素的应用及研究进展[J].现代肿瘤医学,2013,21(1):194-197.
-
1张珉.血管生长抑制素的研究进展[J].国外医学（药学分册）,2002,29(2):78-82.
-
2曹锦花,王凤山,张天民.抑素的研究概况[J].中国生化药物杂志,1999,20(4):212-214.
-
3世界首个血管抑制素抗癌新药上市[J].华夏医药,2009,4(6):418-418.
-
4魏开敏.合理应用钙拮抗剂[J].家庭医学（上半月）,1998,13(22):24-24.
-
5王蕾,许晶,宋岩.奥曲肽的临床应用进展[J].华北国防医药,2009,21(5):26-27. 被引量：17
-
6李骏,梁金玲,麦高阳.百令胶囊联合利拉鲁肽治疗早期糖尿病肾病的疗效观察[J].现代药物与临床,2016,31(2):174-177. 被引量：26
-
7李玉英,钱桂生,黄桂君.血管生成抑制剂Canstatin研究概况[J].生物医学工程学杂志,2005,22(3):626-628. 被引量：2
-
8王德心,刘红岩,黄磊,林浩,韩锐.骨抑素的结构改造及活性初探[J].药学学报,2000,35(3):194-197. 被引量：1
-
9李浪,冯建章,郑文岭.血管生成抑制素canstatin的新发现[J].中国病理生理杂志,2002,18(7):862-864. 被引量：6
-
10冯仁田,张天民.抑素的研究进展[J].中国药学杂志,1993,28(10):583-586. 被引量：1
